-+ 0.00%
-+ 0.00%
-+ 0.00%

NFL Biosciences Seeks Patent Extension for Tobacco Dependence Treatment

MT Newswires·11/13/2026 05:38:24
Listen to the news
05:38 AM EST, 11/13/2026 (MT Newswires) -- NFL Biosciences (ALNFL.PA) filed a new patent request to extend the protection for NFL-102, an immunotherapy for the treatment of tobacco dependence, into new therapeutic applications. The extension focuses on neurotransmitters that impact tobacco and nicotine dependence, according to a Friday release. The biopharmaceutical company expects the patent to run until 2047, excluding potential regulatory extensions, if approved. NFL Biosciences added that the new filing expands its existing intellectual property portfolio of five complementary patent families.